Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 444


MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy.

Ahmad P, Sana J, Slavik M, Gurin D, Radova L, Gablo NA, Kazda T, Smilek P, Horakova Z, Gal B, Hermanova M, Slampa P, Slaby O.

Cancer Genomics Proteomics. 2019 Mar-Apr;16(2):139-146. doi: 10.21873/cgp.20119.


Serum Proteomic Signatures of Male Breast Cancer.

Zografos E, Anagnostopoulos AK, Papadopoulou A, Legaki E, Zagouri F, Marinos E, Tsangaris GT, Gazouli M.

Cancer Genomics Proteomics. 2019 Mar-Apr;16(2):129-137. doi: 10.21873/cgp.20118.


Correlation of TERT and Stem Cell Markers in the Context of Human Breast Cancer.

Wazir U, Orakzai MMAW, Martin TA, Jiang WG, Mokbel K.

Cancer Genomics Proteomics. 2019 Mar-Apr;16(2):121-127. doi: 10.21873/cgp.20117.


MicroRNAs as Potential Targets for Therapeutic Intervention With Metastasis of Non-small Cell Lung Cancer.

Weidle UH, Birzele F, Nopora A.

Cancer Genomics Proteomics. 2019 Mar-Apr;16(2):99-119. doi: 10.21873/cgp.20116. Review.


Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or TET2 Mutation?

Song J, Moscinski L, Zhang H, Zhang X, Hussaini M.

Cancer Genomics Proteomics. 2019 Jan-Feb;16(1):91-98. doi: 10.21873/cgp.20115.


A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (PBMCs) to Identify Candidate Biomarkers of Pancreatic Cancer.

Li H, Mao Y, Xiong Y, Zhao HH, Shen F, Gao X, Yang P, Liu X, Fu D.

Cancer Genomics Proteomics. 2019 Jan-Feb;16(1):81-89. doi: 10.21873/cgp.20114.


MiR-1 Suppresses Proliferation of Osteosarcoma Cells by Up-regulating p21 via PAX3.

Fujii R, Osaka E, Sato K, Tokuhashi Y.

Cancer Genomics Proteomics. 2019 Jan-Feb;16(1):71-79. doi: 10.21873/cgp.20113.


Three Poliovirus Sequences in the Human Genome Associated With Colorectal Cancer.

Lehrer S, Rheinstein PH.

Cancer Genomics Proteomics. 2019 Jan-Feb;16(1):65-70. doi: 10.21873/cgp.20112.


Isoforms of Ionotropic Glutamate Receptor GRIK2 Induce Senescence of Carcinoma Cells.

Zhawar VK, Kandpal RP, Athwal RS.

Cancer Genomics Proteomics. 2019 Jan-Feb;16(1):59-64. doi: 10.21873/cgp.20111.


Human Periprostatic Adipose Tissue: Secretome from Patients With Prostate Cancer or Benign Prostate Hyperplasia.

Sacca PA, Mazza ON, Scorticati C, Vitagliano G, Casas G, Calvo JC.

Cancer Genomics Proteomics. 2019 Jan-Feb;16(1):29-58. doi: 10.21873/cgp.20110.


Multiregion Genomic Analysis of Serially Transplanted Patient-derived Xenograft Tumors.

Sato K, Niida A, Masuda T, Shimizu D, Tobo T, Kuroda Y, Eguchi H, Nakagawa T, Suzuki Y, Mimori K.

Cancer Genomics Proteomics. 2019 Jan-Feb;16(1):21-27. doi: 10.21873/cgp.20109.


The Functional Role of Prostate Cancer Metastasis-related Micro-RNAs.

Weidle UH, Epp A, Birzele F, Brinkmann U.

Cancer Genomics Proteomics. 2019 Jan-Feb;16(1):1-19. doi: 10.21873/cgp.20108. Review.


NOTUM Is Involved in the Progression of Colorectal Cancer.

Yoon JH, Kim D, Kim J, Lee H, Ghim J, Kang BJ, Song P, Suh PG, Ryu SH, Lee TG.

Cancer Genomics Proteomics. 2018 Nov-Dec;15(6):485-497. doi: 10.21873/cgp.20107.


Tumor Susceptibility Gene 101 Mediates Anoikis Resistance of Metastatic Thyroid Cancer Cells.

Saharat K, Lirdprapamongkol K, Chokchaichamnankit D, Srisomsap C, Svasti J, Paricharttanakul NM.

Cancer Genomics Proteomics. 2018 Nov-Dec;15(6):473-483. doi: 10.21873/cgp.20106.


Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab.

Christodoulou C, Oikonomopoulos G, Koliou GA, Kostopoulos I, Kotoula V, Bobos M, Pentheroudakis G, Lazaridis G, Skondra M, Chrisafi S, Koutras A, Bafaloukos D, Razis E, Papadopoulou K, Papakostas P, Kalofonos HP, Pectasides D, Skarlos P, Kalogeras KT, Fountzilas G.

Cancer Genomics Proteomics. 2018 Nov-Dec;15(6):461-471. doi: 10.21873/cgp.20105.


Novel Combination of Arsenic Trioxide (As2O3) Plus Resveratrol in Inducing Programmed Cell Death of Human Neuroblastoma SK-N-SH Cells.

Yen CM, Tsai CW, Chang WS, Yang YC, Hung YW, Lee HT, Shen CC, Sheu ML, Wang JY, Gong CL, Cheng WY, Bau DT.

Cancer Genomics Proteomics. 2018 Nov-Dec;15(6):453-460. doi: 10.21873/cgp.20104.


mRNA Expression of CDK2AP1 in Human Breast Cancer: Correlation with Clinical and Pathological Parameters.

Gera R, Mokbel L, Jiang WG, Mokbel K.

Cancer Genomics Proteomics. 2018 Nov-Dec;15(6):447-452. doi: 10.21873/cgp.20103.


MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas.

Johannessen LE, Brandal P, Myklebust TÅ, Heim S, Micci F, Panagopoulos I.

Cancer Genomics Proteomics. 2018 Nov-Dec;15(6):437-446. doi: 10.21873/cgp.20102.


Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas.

Romanidou O, Kotoula V, Fountzilas G.

Cancer Genomics Proteomics. 2018 Sep-Oct;15(5):421-436. doi: 10.21873/cgp.20101. Review.


Indirect Down-regulation of Tumor-suppressive let-7 Family MicroRNAs by LMO1 in Neuroblastoma.

Saeki N, Saito A, Sugaya Y, Amemiya M, Sasaki H.

Cancer Genomics Proteomics. 2018 Sep-Oct;15(5):413-420. doi: 10.21873/cgp.20100.

Supplemental Content

Loading ...
Support Center